Home » Shop » Feminized Seeds » Boston Tea Party #22

Boston Tea Party #22 Feminized Seeds by Captain Seeds - Balanced hybrid with citrus and herbal tea notes. Moderate grow difficulty. Flowers in eight to ten weeks.
Boston Tea Party #22 blends citrus top notes with herbal tea mid tones and an earthy base. The hybrid sits balanced between head clarity and body ease. Plants respond well to training and moderate feeding. Expect 20-25% THC and low CBD. Flowering spans eight to ten weeks with indoor yields around 400-600 g/m2. Outdoor growers report best results in Mediterranean climates. Harvest when trichomes are mostly cloudy with amber highlights. Dry and cure slowly to preserve terpenes and smooth the smoke.
All the essential strain details at a glance for growers and users.
| Property | Value | Description |
|---|---|---|
|
|
Hybrid | Boston Tea Party #22 is a balanced hybrid for mixed effects. |
|
|
20-25% | Expect 20-25% THC in cured flower. |
|
|
0.5-1% | CBD stays low at 0.5-1%. |
|
|
Moderate | Moderate difficulty suits growers with prior experience. |
|
|
8-10 | Flowering runs eight to ten weeks. |
|
|
Medium-High (400-600 g/m2) | Indoor yields average 400-600 g per square meter. |
|
|
Short to Medium (60-120 cm) | Plants reach 60-120 cm under controlled indoor conditions. |
|
|
Indoor/Outdoor | Performs well both indoors and outdoors in warm climates. |
|
|
Uplifting, Focused, Relaxing | Delivers uplifting focus with a mellow body relax. |
|
|
Citrus, Herbal tea, Earthy | Shows citrus top notes, herbal tea mid tones, and an earthy finish. |
|
|
Boston Cream x Tea Party OG | Genetics come from Boston Cream x Tea Party OG. |
|
|
Feminized Seeds | Available as Feminized seed for predictable female growth. |
|
|
Mediterranean | Prefers Mediterranean climates with warm days and cool nights. |
Answers to Common Questions About Growing Boston Tea Party #22 Cannabis Seeds
No reviews yet. Be the first to review this product!
Sign up for strain updates, exclusive deals, and growing tips. Get 10% off your first order today.